Dr. Paul D Boone, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 7780 S Broadway Ste 350, Littleton, CO 80122 Phone: 720-638-7500 Fax: 720-583-6770 |
Dr. Wissam Asfahani, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 7780 S Broadway Ste 350, Littleton, CO 80122 Phone: 720-638-7500 Fax: 720-583-6770 |
Abhijeet Gummadavelli, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 7780 S Broadway Ste 350, Littleton, CO 80122 Phone: 720-638-7500 |
Mrs. Jennifer Rebecca Sousa, AGNP-C Neurological Surgery Medicare: Medicare Enrolled Practice Location: 7780 S Broadway Ste 350, Littleton, CO 80122 Phone: 720-638-7500 Fax: 720-583-6770 |
Dr. John Adair Prall, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 7780 S Broadway, Suite 350, Littleton, CO 80122 Phone: 720-638-7500 Fax: 303-649-7030 |
Kelly L Mowrey, RN,MS, ANP-C, CNRN Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 7780 S Broadway Ste 350, Littleton, CO 80122 Phone: 720-638-7500 Fax: 720-583-6770 |
Dr. Adam P. Smith, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 7780 S Broadway, #350, Littleton, CO 80122 Phone: 720-638-7500 Fax: 720-583-6770 |
Dr. Herbert Ira Fried, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 4591 Tule Lake Dr, Littleton, CO 80123 Phone: 720-323-5855 |
Dr. Erasmus G. Morfe, D.O. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 7780 S Broadway Ste 350, Littleton, CO 80122 Phone: 720-996-1260 Fax: 303-586-2292 |
Dr. Evan Kyle Winograd, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 Park Central Dr, Littleton, CO 80129 Phone: 720-848-0000 Fax: 678-312-2730 |
Joshua Marshall Beckman, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 7780 S Broadway Ste 350, Littleton, CO 80122 Phone: 720-638-7500 Fax: 720-583-6770 |
Dr. David P. Vansickle, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 7750 S Broadway Ste 350, Littleton, CO 80122 Phone: 720-638-7500 Fax: 720-583-6770 |
Dr. Angela Bohnen, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 7780 S Broadway Ste 350, Littleton, CO 80122 Phone: 720-638-7500 |
News Archive
With the realization that half of the people experiencing a sudden mortal heart attack were taking aspirin on the day of their demise, and the fact that higher-than-recommended doses of aspirin are needed to prevent blood clot formation in coronary arteries, coupled with an announcement that the red wine molecule resveratrol (rez-vair-ah-trawl) may protect from sudden mortal heart attack in a superior fashion to aspirin, suggests re-evaluation of cardiology's current instruction regarding prevention of heart attacks, says Nate Lebowitz MD, cardiologist with the Advanced Cardiology Institute in Ft. Lee, New Jersey.
A new study led by a team of Boston University School of Public Health researchers suggests a link between polyfluoroalkyl chemicals (PFCs), industrial compounds which are widely used in many consumer products, and attention deficit hyperactivity disorder (ADHD) in children.
Much of the body's chemistry is controlled by the brain - from blood pressure to appetite to food metabolism. In a study published recently in Developmental Cell, a team of scientists led by Dr. Gil Levkowitz of the Weizmann Institute has revealed the exact structure of one crucial brain area in which biochemical commands are passed from the brain cells to the bloodstream and from there to the body. In the process, they discovered a surprising new role for the 'hormone of love,' showing that it helps to direct the development of this brain structure.
Mylan today reported that it has identified multiple flaws within a purported bioequivalence study sponsored by Bayer Inc. of Canada. The study compared Bayer's antihypertensive Adalat(R) XL(R) tablets, 60 mg, marketed in Canada, to Mylan's approved generic version, Mylan-Nifedipine Extended Release tablets, 60 mg, marketed in Canada.
› Verified 1 days ago